
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ab Science Sa | LSE:0Q77 | London | Ordinary Share | FR0010557264 | AB SCIENCE ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 3.835 | 3.74 | 3.93 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
144 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 970k | -11.99M | -0.2572 | -5.17 | 178.72M |
Date | Time | Source | Headline |
---|---|---|---|
20/5/2025 | 06:49 | UKREG | AB Science annonce le succès d'un placement privé de 1,8 millions d'euros |
20/5/2025 | 06:49 | UKREG | AB Science announces the successful completion of a EUR 1.8 million private.. |
19/5/2025 | 06:51 | UKREG | AB Science receives Chinese patent protecting masitinib in the treatment of.. |
19/5/2025 | 06:51 | UKREG | AB Science reçoit un brevet chinois protégeant le masitinib dans le.. |
15/5/2025 | 07:07 | UKREG | AB Science annonce aujourd'hui une nouvelle publication dans la revue.. |
15/5/2025 | 07:07 | UKREG | AB Science today reports a new publication in the scientific journal PLOS.. |
12/5/2025 | 07:14 | UKREG | AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre.. |
12/5/2025 | 07:14 | UKREG | AB Science reports its revenues for the year 2024 and provides an update on.. |
05/5/2025 | 17:03 | UKREG | AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de.. |
05/5/2025 | 17:03 | UKREG | AB Science will present new data from masitinib clinical program in ALS in.. |
1 Year Ab Science Chart |
Intraday Ab Science Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions